Enhancing Medication-based Analgesia in Humans

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
PainCannabisOpioid Use, Unspecified
Interventions
DRUG

Within-subject test of blinded study medications

Within-subject double-blind, double-dummy, study design wherein all participants received all doses in 8-hour outpatient sessions. Primary outcomes assessed during 8-hour outpatient sessions and included laboratory pain testing, subjective reports of drug effects, and cognitive performance, evaluated as a function of study medication condition.

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02901275 - Enhancing Medication-based Analgesia in Humans | Biotech Hunter | Biotech Hunter